Value of Ki-67 immunolabelling as a prognostic factor in prostate cancer
Aaltomaa, S, Lipponen, P, Vesalainen, S, Ala-Opas, M, Eskelinen, M, Syrjänen, K
Published in European urology (01.01.1997)
Published in European urology (01.01.1997)
Get more information
Journal Article
Quantification of prostate specific antigen mRNA levels in circulation after prostatic surgery and endocrine treatment by quantitative reverse transcription-polymerase chain reaction
Lintula, S., Vesalainen, S., Rannikko, A., Zhang, W.-M., Finne, P., Stenman, J., Stenman, U.-H.
Published in Scandinavian journal of clinical and laboratory investigation (01.04.2004)
Published in Scandinavian journal of clinical and laboratory investigation (01.04.2004)
Get full text
Journal Article
Tumor vascularity and basement membrane structure as prognostic factors in T1-2MO prostatic adenocarcinoma
Vesalainen, S, Lipponen, P, Talja, M, Alhava, E, Syrjänen, K
Published in Anticancer research (01.03.1994)
Get more information
Published in Anticancer research (01.03.1994)
Journal Article
Nuclear morphometry is of independent prognostic value only in T1 prostatic adenocarcinomas
Vesalainen, S, Lipponen, P, Talja, M, Kasurinen, J, Syrjänen, K
Published in The Prostate (01.08.1995)
Published in The Prostate (01.08.1995)
Get more information
Journal Article
Measurement of the complex between prostate-specific antigen and α1-protease inhibitor in serum
ZHANG, W.-M, FINNE, P, LEINONEN, J, VESALAINEN, S, NORDLING, S, STENAN, U.-H
Published in Clinical chemistry (Baltimore, Md.) (01.06.1999)
Published in Clinical chemistry (Baltimore, Md.) (01.06.1999)
Get full text
Conference Proceeding
Journal Article
Characterization and immunological determination of the complex between prostate-specific antigen and α2-macroglobulin
ZHANG, W.-M, FINNE, P, LEINONEN, J, VESALAINEN, S, NORDLING, S, RANNIKKO, S, STENMAN, U.-H
Published in Clinical chemistry (Baltimore, Md.) (01.12.1998)
Published in Clinical chemistry (Baltimore, Md.) (01.12.1998)
Get full text
Journal Article
Measurement of the complex between prostate-specific antigen and alpha1-protease inhibitor in serum
Zhang, W M, Finne, P, Leinonen, J, Vesalainen, S, Nordling, S, Stenman, U H
Published in Clinical chemistry (Baltimore, Md.) (01.06.1999)
Get full text
Published in Clinical chemistry (Baltimore, Md.) (01.06.1999)
Journal Article
Characterization and immunological determination of the complex between prostate-specific antigen and alpha2-macroglobulin
Zhang, W M, Finne, P, Leinonen, J, Vesalainen, S, Nordling, S, Rannikko, S, Stenman, U H
Published in Clinical chemistry (Baltimore, Md.) (01.12.1998)
Get full text
Published in Clinical chemistry (Baltimore, Md.) (01.12.1998)
Journal Article
Results of the primary treatment in T1-3M0 prostatic adenocarcinoma are dependent on tumour biology
Vesalainen, S, Lipponen, P, Nordling, S, Talja, M, Syrjänen, K
Published in Anticancer research (01.03.1995)
Get more information
Published in Anticancer research (01.03.1995)
Journal Article